Lyell Immunopharma, Inc. (LYEL)
Lyell Immunopharma Market Cap: 377.75M for Jan. 22, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insmed, Inc. | 34.19B |
| Nektar Therapeutics | 631.47M |
| GT Biopharma, Inc. | 7.552M |
| Ionis Pharmaceuticals, Inc. | 13.26B |
| Regeneron Pharmaceuticals, Inc. | 79.38B |
Market Cap Related Metrics
| PS Ratio | 92504.49 |
| PEG Ratio | -0.0005 |
| Price to Book Value | 1.148 |
| Price | 25.51 |
| Earnings Yield | -76.80% |
| PEGY Ratio | -0.0005 |